- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

EC approves AstraZeneca and Merck’s Lynparza for two cancer types

The approval is backed by a biomarker subgroup analysis of the PAOLA-1 Phase III trial. Credit: Nephron